-
US Landline
619-866-6000
- Start your evaluation
US Landline
619-866-6000
Degenerative Diseases
Scleroderma can be grouped into an autoimmune disease of the connective tissues. The word was first described by the Greeks, sclera meaning hard and derma meaning skin and hence hardening of the skin is one of the most visible manifestations of the disease.
Initially, the disease was known as the progressive systemic sclerosis but the term has changed to systemic sclerosis only as it is not necessarily progressive and is patient specific. It has been confirmed that the disease is not contagious, cancerous or malignant.
How can GIOSTAR's Stem Cell Therapy help?
We have mastered the technology for isolating maximum number of viable stem cells from either the autologous sources of your own body or allogeneically with the matched donor to treat various patients with Scleroderma.
GIOSTAR's Stem Cell Therapy can repopulate the damaged parts of the organ, through it's strong paracrine effects and can differentiate into lost or damaged cells to restore back the function. These cells can regulate the immune system and minimize the impact of autoimmunity. One of the important properties of mesenchymal stem cells is to promote vascularization and vessel formation, which can improve the strength of the blood vessels and also promote synthesis of new vessels. When infused in the deep layer of the skin, these stem cells are known to promote synthesis of lost fibroblasts, keratinocytes and skin epithelial cells to promote faster restructuring of cells.
Stem cell therapy like any other type of medical procedure have no guarantees and is not promoted as a cure. Reviews and testimonials on this site are personal experiences of our patients. An evaluation from the medical team is required to determine if you are a candidate for stem cell therapy and any personal information provided is for internal and medical use only at GIOSTAR. GIOSTAR hearquarters and research is done in San Diego, California. Adipose Derived Minimally Manipulated Autologous Stem Cell Therapy is regulated by the Federal Drug Administration (FDA) under these guidelines and generally falls under physician's discretion via exception in 21 CFR 1271.15(b) in the United States. Canadian laws state that stem cell therapy is approved only for research. Stem cell therapy at GIOSTAR Mexico is regulated and approved by COFEPRIS and other local authorities and is practiced within the legal limits of Mexico.